Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer.
about
Prediction of Bacillus Calmette-Guerin Response in Patients with Bladder Cancer after Transurethral Resection of Bladder Tumor by Using Genetic Variation Based on Genomic StudiesPADB: published association databasePotentially functional variants in the core nucleotide excision repair genes predict survival in Japanese gastric cancer patients.Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast cancer.Modulation of nucleotide excision repair in human lymphocytes by genetic and dietary factors.A functional analysis of G23A polymorphism and the alternative splicing in the expression of the XPA gene.An association between DNA repair gene polymorphisms and survival in patients with resected non-small cell lung cancer.Molecular cloning and gene expression analysis of Ercc6l in Sika deer (Cervus nippon hortulorum).Acute myeloid leukemia of donor origin after allogeneic stem cell transplantation from a sibling who harbors germline XPD and XRCC3 homozygous polymorphisms.Genetic variations of the PI3K-AKT-mTOR pathway and clinical outcome in muscle invasive and metastatic bladder cancer patientsGenetic variations in the sonic hedgehog pathway affect clinical outcomes in non-muscle-invasive bladder cancerInfluence of DNA repair gene polymorphisms on prognosis in inoperable non-small cell lung cancer patients treated with radiotherapy and platinum-based chemotherapy.Hypertension, diuretics and antihypertensives in relation to bladder cancer.Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes.The survival impact of XPA and XPC genetic polymorphisms on patients with esophageal squamous cell carcinoma.Variants in nucleotide excision repair core genes and susceptibility to recurrence of squamous cell carcinoma of the oropharynx.Comprehensive pathway-based interrogation of genetic variations in the nucleotide excision DNA repair pathway and risk of bladder cancer.Susceptibility of XPD and RAD51 genetic variants to carcinoma of urinary bladder in North Indian populationGefitinib in Combination with Weekly Docetaxel in Patients with Metastatic Breast Cancer Caused Unexpected Toxicity: Results from a Randomized Phase II Clinical Trial.Predictive biomarkers of bacillus calmette-guérin immunotherapy response in bladder cancer: where are we now?The pharmacogenetic impact of inflammatory genes on bladder cancer recurrence.The Cellular Response to Oxidatively Induced DNA Damage and Polymorphism of Some DNA Repair Genes Associated with Clinicopathological Features of Bladder Cancer.ATM sequence variants associate with susceptibility to non-small cell lung cancerGenetic variability in DNA repair proteins in age-related macular degeneration.Modulation of DNA damage/DNA repair capacity by XPC polymorphismsDNA repair gene polymorphisms may be associated with prognosis of upper urinary tract transitional cell carcinomaSingle nucleotide polymorphisms in DNA repair genes might be prognostic factors in muscle-invasive bladder cancer patients treated with chemoradiotherapy.The polyAT, intronic IVS11-6 and Lys939Gln XPC polymorphisms are not associated with transitional cell carcinoma of the bladderA variant of the Cockayne syndrome B gene ERCC6 confers risk of lung cancer.Genetic variations in cell-cycle pathway and the risk of oral premalignant lesionsCancer pharmacogenomics: role of DNA repair genetic polymorphisms in individualizing cancer therapy.Independent Replication of Published Germline Polymorphisms Associated with Urinary Bladder Cancer Prognosis and Treatment ResponsePolymorphisms in the XRCC1 gene modify survival of bladder cancer patients treated with chemotherapyGenetic epidemiology of bladder cancer: scaling up in the identification of low-penetrance genetic markers of bladder cancer risk and progression.Gene signatures for risk-adapted treatment of bladder cancer.Germline prognostic markers for urinary bladder cancer: obstacles and opportunities.Germline genetic markers for urinary bladder cancer risk, prognosis and treatment response.Epistatic SNP interaction of ERCC6 with ERCC8 and their joint protein expression contribute to gastric cancer/atrophic gastritis risk.Association between DNA-repair polymorphisms and survival in pancreatic cancer patients treated with combination chemotherapy.An association between XPC Lys939Gln polymorphism and the risk of bladder cancer: a meta-analysis.
P2860
Q28076563-F067BA05-C119-433A-9C2F-1D19A99BE26CQ28221773-BF105408-4BE0-4045-9673-3DE403E969E1Q31170960-5FF5FF8D-E435-4DAA-8FD4-0AB8704E2480Q33383830-778A1ED0-C183-41C9-9A49-0DA7D2FDD2D7Q33514150-6D497762-0094-4BF3-AAA2-0BF7364F861FQ33701903-0948AB6D-7ADF-4BA6-9702-1E0DC2A683B2Q33781302-B4C2356E-A460-4598-A782-BDBE8EF60DD7Q33939248-F7A5AE22-71D0-4B47-A651-C38E10A8AC3BQ34032840-36242A92-FCEE-4CE1-9748-3A16034A3424Q34042341-BCB3DBF1-E14C-4502-863A-CA2D8F11CD19Q34203675-ABA74DD5-EBAB-490D-A385-C53F251B21BBQ34236406-DEB18D12-9E98-4396-B55F-8A8FB6CDA04EQ34253363-51BD13A4-B7AF-49B3-8694-F8BB1AEC5152Q34399048-58128825-F190-46D4-B2C5-993316C3EC8EQ34401264-D58757DC-B3BF-440B-BE02-2B9E8EB3137AQ34555379-A8EA60B8-84FB-4739-8B62-9ECBF83461A6Q35228293-82CE5FD5-7599-4363-A16A-E1A946298737Q35737487-89E5E0A5-D991-48FE-B2E9-2C525166030AQ35990886-CB67231B-132B-4103-8868-A8B06F271A61Q36167778-B922E588-423E-40F9-AC14-DE07BC3E4117Q36249221-CC62E9AD-0C1D-4B1A-9386-A25C756C95ABQ36328938-0E7A6D46-039F-4FFA-A9D0-43C8371622EBQ36337552-50EB6308-4A6A-41F1-976B-35D0FF9F7350Q36396574-98CEF122-509E-4A7C-B61D-767725A42A27Q36478743-58932FFD-1CA5-465F-A0E8-C664E44D4DDAQ36485288-695B4C5C-D40E-4021-8F88-DA59497BF3F5Q36612270-0293DA30-4898-4813-9E16-340957ABD90AQ36616018-1025D18B-56C0-4D43-AD8C-80BB5406423AQ36739715-3B649379-6641-4267-9282-A74A3B50B505Q36959346-026900B5-301B-4B9F-9DE6-71ED476ED015Q37031517-1E81AC76-77DF-4DC9-BA7C-CE26125AB52DQ37054113-55FFD78B-6B8B-466B-8B1F-61347459365BQ37244332-69550B3D-173B-4B6E-9FE1-091229B10E76Q37278993-C8390635-848A-4E63-BA25-83DEFBB0AB4FQ37279004-55318676-E0AD-4393-90B0-828A842DF433Q37298808-3E1BCAD3-4C61-4627-8196-4A1F8C138A58Q37797468-F469C20C-E18D-4307-A59F-0E04371E08AEQ42335721-9C7298A5-9C1B-4692-98E8-FB4F30C950F1Q42725709-8EE2D2BC-8A97-4828-8D4F-A04D0482A27BQ48104030-867BBF1E-CAFE-4BB5-8B6C-90E828CA2A46
P2860
Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Nucleotide excision repair gen ...... or superficial bladder cancer.
@ast
Nucleotide excision repair gen ...... or superficial bladder cancer.
@en
type
label
Nucleotide excision repair gen ...... or superficial bladder cancer.
@ast
Nucleotide excision repair gen ...... or superficial bladder cancer.
@en
prefLabel
Nucleotide excision repair gen ...... or superficial bladder cancer.
@ast
Nucleotide excision repair gen ...... or superficial bladder cancer.
@en
P2093
P1476
Nucleotide excision repair gen ...... for superficial bladder cancer
@en
P2093
Carlos E Bermejo
Colin P Dinney
Dan Leibovici
H Barton Grossman
P304
P356
10.1158/1078-0432.CCR-04-1101
P407
P50
P577
2005-02-01T00:00:00Z